Cardiol Therapeutics Inc. Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019
Cardiol Therapeutics Inc. (CRDL) had Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 of 1.73 CAD/shares as of 2025-12-31, per its 40-F filed 2026-03-31.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsOutstandingInSharebasedPaymentArrangement2019 · last filed 2026-03-31
- 2025-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 1.73 CAD/shares.
- 2024-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 2.76 CAD/shares.
- 2023-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 2.44 CAD/shares.
- 2022-12-31: Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 3.52 CAD/shares.
| Period end | Weighted Average Exercise Price Of Share Options Outstanding In Share-based Payment Arrangement2019 |
|---|---|
| 2025-12-31 | 1.73 CAD/shares 40-F · filed 2026-03-31 |
| 2024-12-31 | 2.76 CAD/shares 40-F · filed 2026-03-31 |
| 2023-12-31 | 2.44 CAD/shares 40-F · filed 2026-03-31 |
| 2022-12-31 | 3.52 CAD/shares 40-F · filed 2025-03-31 |
| 2021-12-31 | 4.16 CAD/shares 20-F · filed 2024-04-01 |
| 2020-12-31 | 3.78 CAD/shares 20-F · filed 2024-04-01 |
| 2019-12-31 | 4.68 CAD/shares 20-F · filed 2023-03-29 |